Gestational Diabetes. Diabetes mellitus arising in pregnancy
Conditions
Interventions
Intervention 1: Protocol A: In this protocol, the screening test in first pregnancy trimester will be fasting blood sugar (FBS). In addition, all of women with mild gestational diabetes will receive s
Treatment - Drugs
Protocol A: In this protocol, the screening test in first pregnancy trimester will be fasting blood sugar (FBS). In addition, all of women with mild gestational diabetes will receive standard treatmen
Protocol B: In this protocol, the screening test in first pregnancy trimester will be fasting blood sugar (FBS). In addition, all of women with mild gestational diabetes will not receive standard trea
Protocol C: In this protocol, the screening test in first pregnancy trimester will be fasting blood sugar (FBS). In addition, all of women with mild gestational diabetes will not receive standard trea
Protocol D: In this protocol, the screening test in first pregnancy trimester will be fasting blood sugar (FBS). In addition, all of women with mild gestational diabetes will receive standard treatmen
Protocol E: In this protocol, the screening test in first pregnancy trimester will be fasting blood sugar (FBS). In addition, all of women with mild gestational diabetes will not receive standard trea
Sponsors
National institute for medical research development
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: All 1st trimester pregnant women who refer from health centers of selected cities among 5 provinces will recruit to the study Exclusion criteria: Preexisting diabetes; Prior gestational diabetes; A history of stillbirth; Multifetal gestation; Asthma; Chronic hypertension; Taking corticosteroids
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cost of health services including pregnancy, delivery and neonatal period. Timepoint: After expenses in each phase. Method of measurement: View, record and receive expenses factors.;Quality-adjusted life years (QALYs). Timepoint: pregnancy, delivery and neonatal period. Method of measurement: Quality-adjusted life years (QALYs).;Percentage of birth weight>90th percentile. Timepoint: at the time of delivery. Method of measurement: Using fetal growth curves.;Percentage of primary cesarean section. Timepoint: at the time of delivery. Method of measurement: View and registered cases of primary cesarean.;Percentage of neonatal hypoglycemia. Timepoint: At first hour after birth. Method of measurement: Measurment the blood glucose levels using a laboratory glucose kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Percentage of birth weight<10th percentile. Timepoint: After delivery. Method of measurement: Using fetal growth curves.;The percentage of admission to the neonatal intensive care unit. Timepoint: neonatal period (T the time of birth until day 28 after birth). Method of measurement: Observation and record.;Birth trauma including fracture of clavicle, brachial plexus injury. Timepoint: At the time of delivery. Method of measurement: Observation and record.;Still birth(intra uterine death). Timepoint: delivery. Method of measurement: delivery registry.;Preeclampsia. Timepoint: 2nd and 3rd trimesters. Method of measurement: prenatal records.;Preterm labor. Timepoint: delivery. Method of measurement: delivery registry.;Shoulder dystocia. Timepoint: delivery. Method of measurement: delivery registry.;Neonatal hyperbilirubinemia. Timepoint: neonatal period. Method of measurement: blood bilirubine.;Neonatal hypocalcaemia. Timepoint: neonatal period. Method of measurement: blood calcium. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFahimeh Ramezani Tehrani
Reproductive Endocrinology Research Center Research Institute for Endocrine Sciences Shahid Behesht
Outcome results
None listed